Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960

Diagn Microbiol Infect Dis. 2017 Feb;87(2):108-111. doi: 10.1016/j.diagmicrobio.2016.10.023. Epub 2016 Oct 30.

Abstract

A rapid detection of resistance in Mycobacterium tuberculosis is crucial for management and control of tuberculosis. This study evaluated a more rapid and cost-effective drug susceptibility testing (DST) protocol using primary isolates of M. tuberculosis in mycobacteria growth indicator tube (MGIT). Ninety-four M. tuberculosis isolates in MGIT were subjected to DST by the manufacturer's method, i.e., primary isolates were subcultured and DST was performed from positive cultures for a maximum of 5days; and by our modified method, i.e., DST was performed directly from primary MGIT cultures positive for more than 5days. Results were concordant for 76 (81%) isolates. Agreement between both methods was 92.0%, 98.9%, 97.7%, and 95.5% for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. Six isolates failed to grow on the recommended method, including 3 resistant isolates. Not performing subculture of primary M. tuberculosis isolates yields reliable results, decreasing the turnaround time and the cost of the test.

Keywords: Diagnostics; Drug resistance; MGIT 960; Mycobacterium tuberculosis; Tuberculosis.

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Microbial Sensitivity Tests / methods*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Time Factors
  • Tuberculosis / diagnosis
  • Tuberculosis / microbiology

Substances

  • Antitubercular Agents